Novavax (NVAX) Other financing activities (2010 - 2022)

Novavax's Other financing activities history runs 13 years deep, the most recent figure standing at -$983000.0 for Q3 2022.

• On a quarterly basis, Other financing activities rose 82.0% year-over-year to -$983000.0 in Q3 2022; TTM through Sep 2022 was $3.4 million, a 138.12% increase from a year earlier, with the FY2021 full-year figure at $24.8 million, up 360.07% from the prior year.
• Other financing activities retreated to -$983000.0 in Q3 2022 per NVAX's latest filing, from -$268000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $26.8 million in Q3 2020 and bottomed at -$30.3 million in Q4 2020.
• The 5-year median for Other financing activities is $942000.0 (2019), against an average of $2.0 million.
• Biggest YoY gain for Other financing activities was 481880.0% in 2021; the steepest drop was 120.42% in 2021.
• Year by year, Other financing activities stood at $283000.0 in 2018, then tumbled by 82.33% to $50000.0 in 2019, then sank by 60752.0% to -$30.3 million in 2020, then soared by 110.95% to $3.3 million in 2021, then tumbled by 129.61% to -$983000.0 in 2022.
• Per Business Quant, the three latest NVAX Other financing activities figures stand at -$983000.0 (Q3 2022), -$268000.0 (Q2 2022), and $1.3 million (Q1 2022).